Spectranetics Still Searching For Traction In Peripheral

Spectranetics Corporation (SPNC) Citi 2013 Global Healthcare Conference Call February 26, 2013 11:05 AM ET Executives Scott Drake – CEO Guy Childs – CFO Analysts Amit Bhalla – Citi Presentation Amit Bhalla

Jessica Breen submits:[[SAP]]’s refocus on customers and innovation paid off with double digit software growthSAP reported record software revenue of 35% year-to-year as it reached €1.5 billion in its fourth quarter.

Vascular Solutions, Inc. (VASC) Bank of America Merrill Lynch Health Care Conference Call May 15, 2013 8:00 pm ET Executives James Hennen – Senior Vice President-Finance, Secretary and Chief Financial Officer Presentation Unidentified Analyst

By Markus Aarnio: When insiders buy shares on the open market, their companies are usually undervalued. Corporate insiders often have the inside track on their companies' prospects. Insiders probably wouldn't risk investing too much of their own money into their own companies unless they thought the stock might rise. I screened for companies where at least one insider made an insider buy during the week ending July 20th. Here are five healthcare stocks that I found:

Dr. Stephen Leeb submits:With tax cuts and unemployment benefits extended, things are looking brighter for the US economy in the near-term. The renewed activity is surely being felt in energy markets, with the largest oil consumer (the US) getting its legs back under it. Crude oil prices are hovering just under $90 per barrel, and the focus is again turning back to the tight gap between production and consumption.

Saj Karsan submits:As value investors, we are trained to look at the "Goodwill" and "Intangibles" lines on a company's balance sheet with great skepticism. After all, these supposed company assets are not hard assets like equipment or land or receivables and therefore can't be used to generate cash flows and furthermore they have no salvage value.

By Ingrid Hendershot: Seeking income in a low-yield world, investors may find high quality, dividend-paying stocks a desirable option. Relative to Treasuries, dividend yields are more attractive than they have been in 50 years. The table below spotlights a dozen Dividend Divas which during the past year have increased their dividends at double-digit rates, demonstrating management’s confidence in their financial strength and long-term growth opportunities.

By Valuentum: Clorox (CLX) reported fiscal first-quarter results Wednesday that showed declining sales in its US categories and higher commodity costs. We weren’t that impressed with the performance, but we are maintaining our $72 per share fair value estimate. Source: Clorox Company Report, Valuentum Securities, Inc.